Skip to content

Effectiveness of homoeopathic medicine on patients of primary hypothyroidism with dyslipidemia

Effectiveness of individualized homoeopathic medicine on primary hypothyroidism with dyslipidemia while assessing the correlation between changes in serum TSH and total cholesterol levels: An open label, prospective, clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080325
Enrollment
30
Registered
2025-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified Health Condition 2: E780- Pure hypercholesterolemia

Interventions

Intervention1: Individualised homoeopathic medicine: individualised homoeopathic medicine will be given orally for 6 months and dose, repetition will be selected on the basis of improvement of patient

Sponsors

Dr. Jyoti Bhushan Dash
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are diagnosed with primary hypothyroidism having serum TSH level more than 5mIU per L and total serum total cholesterol level more than 200mg per dl. Patients aged between 12 to 65 years of all gender religions and socio economic status. Patient who are willing to participate in the study and giving informed consent. If patients taking any Homoeopathic or and Allopathic medicines for primary hypothyroidism and also willing to participate in the study, they will be enrolled in the study after washing period 2 months. Patients who are willing to participate but illiterate then they will be enrolled after verbal explanation and consent, verified by the physicians signature and patients thumb impression. Patients who agree to undergo suggested and relevant investigations, if required.

Exclusion criteria

Exclusion criteria: Patients having secondary hypothyroidism, congenital hypothyroidism and subclinical hypothyroidism. Patients having primary dyslipidemia and secondary dyslipidemia associated of other causes. Pregnant and lactating women. Patients with habit of substance abuse and or dependence. Patients having any psychiatric or life threatening illness or immune compromised state. Patients taking any other substitutional treatment for primary hypothyroidism.

Design outcomes

Secondary

MeasureTime frame
nilTimepoint: nil

Primary

MeasureTime frame
serum TSH & total cholesterol levels.Timepoint: Baseline and 6 months

Countries

India

Contacts

Public ContactProf Dr Gautam Pal

National Institute of Homoeopathy

drjbdash98@gmail.com7504245877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026